Morocco vs Niger: HIV/AIDS deaths averted by antiretroviral therapy
Morocco
1,213 deaths
in 2024
Niger
1,361 deaths
in 2024
Morocco rank
70th
Niger rank
67th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Morocco
- Niger
How they compare
Niger currently reports 1,361 deaths against 1,213 deaths in Morocco, a difference of 148 deaths.
That makes Niger's figure about 1.1 times Morocco's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Niger ahead.
Morocco ranks 70th and Niger ranks 67th of 157 countries.
Niger has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Morocco | Niger | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 183.06 deaths | 290.37 deaths | 107.3 deaths | Niger |
| 2010s | 725.97 deaths | 1,440 deaths | 713.95 deaths | Niger |
| 2020s | 1,101 deaths | 1,431 deaths | 329.64 deaths | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Morocco or Niger?
- Niger, at 1,361 deaths against 1,213 deaths in Morocco as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Morocco and Niger?
- 148 deaths, with Niger ahead.
- How many years of comparable data are there for Morocco and Niger?
- 35 years are reported by both, from 1990 to 2024.
- How do Morocco and Niger rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Morocco ranks 70th and Niger ranks 67th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.